Nothing Special   »   [go: up one dir, main page]

Liu et al., 2018 - Google Patents

Conformation-directed micelle-to-vesicle transition of cholesterol-decorated polypeptide triggered by oxidation

Liu et al., 2018

Document ID
15238446101981881976
Author
Liu H
Wang R
Wei J
Cheng C
Zheng Y
Pan Y
He X
Ding M
Tan H
Fu Q
Publication year
Publication venue
Journal of the American Chemical Society

External Links

Snippet

Hierarchical self-assembly of synthetic polypeptides has attracted increasing interests due to its protein-mimetic structure and great potential in nanotechnology and biomedical applications. However, controlling the morphology and function of polymeric nanostructures …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, copolymers of polyalkylene glycol or poloxamer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Liu et al. Conformation-directed micelle-to-vesicle transition of cholesterol-decorated polypeptide triggered by oxidation
Cui et al. Thermogelling of amphiphilic block copolymers in water: ABA type versus AB or BAB type
Hwang et al. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval
Maiti et al. Redox-responsive core-cross-linked block copolymer micelles for overcoming multidrug resistance in cancer cells
Fan et al. Poly (ethyl glyoxylate)-poly (ethylene oxide) nanoparticles: stimuli-responsive drug release via end-to-end polyglyoxylate depolymerization
Meng et al. Stimuli-responsive polymersomes for programmed drug delivery
Iyisan et al. Multifunctional and dual-responsive polymersomes as robust nanocontainers: design, formation by sequential post-conjugations, and pH-controlled drug release
Thambi et al. Bioreducible block copolymers based on poly (ethylene glycol) and poly (γ-benzyl L-glutamate) for intracellular delivery of camptothecin
Luo et al. pH-sensitive vesicles formed by amphiphilic grafted copolymers with tunable membrane permeability for drug loading/release: a multiscale simulation study
Ryu et al. Redox-sensitive disassembly of amphiphilic copolymer based micelles
Du et al. Evaluation of polymeric micelles from brush polymer with poly (ε-caprolactone)-b-poly (ethylene glycol) side chains as drug carrier
Martín et al. Temperature-triggered self-assembly of elastin-like block co-recombinamers: the controlled formation of micelles and vesicles in an aqueous medium
Sankaranarayanan et al. Multiresponse strategies to modulate burst degradation and release from nanoparticles
Loh et al. Triply triggered doxorubicin release from supramolecular nanocontainers
Lv et al. Unimolecular polypeptide micelles via ultrafast polymerization of N-carboxyanhydrides
Chen et al. pH-responsive chimaeric pepsomes based on asymmetric poly (ethylene glycol)-b-poly (l-leucine)-b-poly (l-glutamic acid) triblock copolymer for efficient loading and active intracellular delivery of doxorubicin hydrochloride
Johnson et al. Poly (PEGA)-b-poly (L-lysine)-b-poly (L-histidine) hybrid vesicles for tumoral pH-triggered intracellular delivery of doxorubicin hydrochloride
Yin et al. Polymersome formation from AB2 type 3-miktoarm star copolymers
Pandey et al. Amphiphilic glycopolypeptide star copolymer-based cross-linked nanocarriers for targeted and dual-stimuli-responsive drug delivery
Ping et al. Supramolecular β-sheets stabilized protein nanocarriers for drug delivery and gene transfection
Li et al. Synthesis and characterization of cleavable core-cross-linked micelles based on amphiphilic block copolypeptoids as smart drug carriers
Zhao et al. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin
Zhu et al. PH-sensitive polymeric vesicles from coassembly of amphiphilic cholate grafted poly (l-lysine) and acid-cleavable polymer–drug conjugate
Du et al. 19F-and fluorescently labeled micelles as nanoscopic assemblies for chemotherapeutic delivery
Kim et al. Natural polypeptide-based supramolecular nanogels for stable noncovalent encapsulation